Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
NUVALENT, INC.
About NUVL
Nuvalent, Inc. is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer. It develops small molecules that have the potential to overcome resistance, minimize adverse events, and address brain metastases. It is advancing a robust pipeline with investigational candidates for ROS proto-oncogene 1 (ROS1)-positive, anaplastic lymphoma kinase (ALK)-positive, and human epidermal growth factor receptor 2 (HER2)-positive non-small cell lung cancer, and multiple discovery-stage research programs. Its product candidate, Zidesamtinib (NVL-520), is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC). NVL-520 is a novel ROS1-selective inhibitor. Its product candidate, Neladalkib (NVL-655), is being developed for patients with ALK-positive NSCLC. NVL-655 is a brain-penetrant ALK-selective inhibitor. Its product candidate, NVL-330, is a brain-penetrant HER2-selective inhibitor.
Find out what a historical investment in NUVALENT, INC. would be worth today using our NUVL stock calculator.
Market Capitalisation
$7.98B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
403.35K
High today
$103.82
Low today
$101.18
Open price
$101.18
52-week high
$113.02
52-week low
$70.25
Ready to start your investing journey with Stake?
Open an accountHow do I buy NUVL shares in Australia?
Buying NUVL shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in NUVALENT, INC. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in NUVL
What is the ticker symbol of NUVALENT, INC.?
The ticker symbol for NUVALENT, INC. is NUVL.
How much is one share of NUVL?
One share of NUVL is valued at $102.47 as of 20 May 2026.
What is the market capitalisation of NUVALENT, INC. NUVL?
As of 20 May 2026 NUVALENT, INC. has a market cap of $7.98B.
What is the 52-week high for NUVALENT, INC. stock?
The NUVALENT, INC. 52-week high stock price is $113.02.
What is the 52-week low for NUVALENT, INC. stock?
The NUVALENT, INC. 52-week low stock price is $70.25.
Can I buy NUVL shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy NUVL shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in NUVL on Stake
- Buy NUVL from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of NUVL from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
NUVL related stocks